A major new study suggests that the United States faces a much larger cholesterol treatment gap than many experts expected.
Researchers found that a large share of adults have LDL cholesterol levels above the targets recommended in the latest national guidelines, leaving many people at unnecessary risk of heart attack and stroke.
Heart disease remains the leading cause of death in many countries. One of the biggest risk factors is LDL cholesterol, sometimes called bad cholesterol because it can collect inside artery walls and reduce blood flow to the heart and brain.
The new research was led by Mass General Brigham and published in JAMA. Scientists wanted to see how well Americans already met the lower LDL goals introduced in the 2026 cholesterol guidelines.
The team analyzed information from approximately 2,300 adults aged 30 to 79 who participated in a nationwide health survey.
The survey represents roughly 178 million adults in the United States, allowing the findings to reflect the broader population.
The updated guidelines recommend different LDL targets depending on a person’s overall cardiovascular risk. Healthy people at lower risk can have higher LDL levels before treatment is considered, while people with previous heart attacks or strokes are advised to keep LDL levels much lower.
The researchers found that almost one-third of adults without heart disease already exceeded the new LDL targets. Among these individuals, roughly three out of every four were not taking any cholesterol-lowering medicine.
The picture was different for people who had already developed heart disease. Nearly four out of five remained above their LDL goal even though many were already taking statins or other cholesterol-lowering drugs. This suggests that treatment may need to be strengthened rather than simply started.
According to the researchers, stronger treatment could include using a higher-dose statin, combining different cholesterol medicines, or using newer therapies when appropriate. The right approach depends on each patient’s health and risk profile.
The study also reminds people that medicines are only one part of cholesterol management. Healthy eating, regular physical activity, maintaining a healthy weight, avoiding smoking, and controlling blood pressure all work together to reduce cardiovascular risk.
The research has several strengths, including the use of a nationally representative database collected before the new guidelines were introduced. This provides a useful benchmark for measuring future progress. However, because it is an observational study, it cannot determine why many people remain untreated or whether guideline adoption will immediately improve outcomes.
In summary, the study suggests millions of Americans may benefit from reviewing their cholesterol levels with their healthcare provider under the updated recommendations. The findings reinforce decades of evidence showing that lowering LDL cholesterol is one of the most effective ways to prevent heart attacks and strokes, especially in people at high risk.
If you care about heart health, please read studies about how vitamin D influences cholesterol levels, and what we know about egg intake and heart disease.
For more health information, please see recent studies about best supplements for heart disease prevention, and wild blueberries can benefit your heart and brain.
Source: Mass General Brigham.
